Johnson & Johnson Gears Up For Q1 Print; Here Are The Recent Forecast Changes From Wall Street's Most Accurate Analysts
1. JNJ to announce Q1 earnings on April 15, 2025. 2. Expected earnings: $2.58/share, down from $2.71/share last year. 3. Projected revenue: $21.57 billion, slight increase from $21.38 billion. 4. Protagonist Therapeutics reported new psoriasis treatment data linked to JNJ. 5. JNJ shares rose 1.7% to close at $154.36.